Nymphaea rubra
Nymphaea rubra · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Nymphaea rubra is a remarkable botanical species recognized for its diverse range of therapeutic potential. The flowers of this plant have garnered significant scientific interest due to their unique bioactive properties. Research indicates that these floral extracts exhibit potent antidiabetic activities that may assist in metabolic regulation. Furthermore, the plant shows promise in managing complex conditions such as adipogenesis and dyslipidemia. Understanding these medicinal qualities highlights the importance of Nymphaea rubra in addressing modern metabolic health challenges.
- Synonyms
- Castalia Rubra · Castalia Magnifica · 4 more
- Common names
- Not available
- Family
- Nymphaeaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Flower
Classification
Common Names
Nymphaea rubra is a captivating aquatic species that is widely recognized by its common name, the red lotus. This striking plant is celebrated for its vibrant crimson blooms that rise gracefully above the water's surface. Often found in tranquil ponds, it adds a dramatic splash of color to any wetland ecosystem. Gardeners and botanists alike admire the plant for both its aesthetic beauty and its unique biological characteristics. Understanding its identity as the red lotus helps enthusiasts appreciate the elegance of this aquatic treasure.
Sources: Catalogue of Life (COL)
Synonyms
Nymphaea rubra is a botanically complex species that has been identified by several different scientific names throughout history. It is frequently referred to by the synonyms Castalia magnifica and Castalia rubra in various taxonomic records. Furthermore, the plant has been categorized under the name Leuconymphaea rubra in older literature. Classification also includes specific subspecies, such as Nymphaea rubra subsp. latipetala, to denote distinct variations. Finally, the name Nymphaea rubra subsp. longiflora serves as another recognized synonym within its diverse lineage.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Nymphaea rubra is a remarkable species belonging to the vast kingdom Plantae. Within this biological realm, it is specifically classified under the class Equisetopsida. The plant is a member of the order Nymphaeales, showcasing its unique evolutionary lineage. It further finds its place within the Nymphaeaceae family, a group known for its aquatic beauty. Ultimately, this striking flower is defined by its membership in the genus Nymphaea.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Nymphaeales |
| Family | Nymphaeaceae |
| Genus | Nymphaea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Nymphaea rubra boasts a widespread presence across various ecological zones throughout the Asian continent. Its range extends into the temperate regions of China, specifically within the southeastern territories. Additionally, the species thrives across the tropical landscapes of the Indian Subcontinent, including parts of Assam and Bangladesh. It is also frequently found growing within the diverse environments of India and Sri Lanka. This broad distribution highlights the plant's ability to adapt to both temperate and tropical climates.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Nymphaea rubra is characterized by its distinct herbaceous growth form. This aquatic plant is entirely self-supporting as it develops within its environment.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Nymphaea rubra flowers exhibit significant antidiabetic properties that offer a promising natural approach to managing metabolic disorders. Research involving STZ-induced diabetic rats demonstrates that extracts from these flowers can effectively regulate blood glucose levels and improve insulin profiles. The study highlights the presence of key bioactive alkaloids, such as Nuciferine and Apomorphine, which likely work synergistically to achieve these therapeutic effects. Beyond glucose control, the plant also shows potential in treating dyslipidemia and suppressing adipogenesis in cellular models. These findings establish a strong biochemical rationale for using Nymphaea rubra as a functional resource in the treatment and control of diabetes.
Compounds
Nymphaea rubra flowers are widely recognized in subtropical regions for their traditional medicinal uses and significant health benefits. Recent GC-MS investigations of the plant's ethanolic extract have identified key marker compounds that drive its therapeutic potential. Specifically, the flowers are found to contain significant concentrations of the alkaloid Nuciferine. Additionally, the plant contains apomorphine, which contributes to the extract's complex chemical profile. The synergistic impact of these bioactive constituents suggests that Nymphaea rubra may play a vital role in the treatment and control of diabetes and dyslipidemia.
Conditions
Nymphaea rubra exhibits significant therapeutic potential by acting to treat diabetes and its associated metabolic complications. The plant extract demonstrates antidiabetic properties through the inhibition of $\alpha$-amylase enzyme activity. Furthermore, Nymphaea rubra helps treat dyslipidemia and addresses dyslipidemic conditions by improving lipid profiles in studied models. Research also indicates that the plant effectively treats adipogenesis by promoting its suppression in 3T3-L1 cells. These combined effects suggest that the bioactive constituents of the flower serve as a strong foundation for managing diabetes and related metabolic disorders.
Preparations
Parts used
Nymphaea rubra contains highly beneficial flowers that are widely utilized in subtropical regions for both dietary and traditional medicinal purposes. Recent scientific investigations have focused on the specific phytoconstituents found within these flowers to evaluate their potential therapeutic properties. Through GC-MS analysis, researchers identified key marker compounds such as Nuciferine and Apomorphine within the floral extracts. These bioactive chemicals demonstrate significant antidiabetic and dyslipidemic effects, particularly in managing blood glucose and lipid profiles. Ultimately, the study suggests that the flower extracts of Nymphaea rubra offer a promising natural foundation for treating diabetes and its associated metabolic conditions.